MUDr. Jan Culak, s.r.o.

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes3 trials
• Heart failure1 trial
• Obesity1 trial

Phase

• Phase 34 trials

Status

• Completed2 trials
• Recruiting2 trials

Lead sponsor

• Novo Nordisk A/S2 trials
• AstraZeneca1 trial
• AstraZeneca AB1 trial

Running trials

• Recruiting

  A Study to evaluate effect of AZD6234 in adult participants with Type 2 Diabetes Mellitus and obesity or overweight

  2025-524616-11-00· Phase 3· AstraZeneca AB· Source

• Recruiting

  Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  NCT06677060· Phase 3· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure1 recruiting
• Obesity1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

  NCT06065540· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

  NCT03914326· Phase 3· Novo Nordisk A/S· Source